Zhuhai Aofute Medical Technology Co., Ltd. · 66-41 · CHINA
For Zhuhai Aofute Medical Technology Co., Ltd. · 66-41 · CHINA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CHINA; product is Magic Spray for Pain Relief | Magic Spray for Pain Relief | Magic Spray for Pain Relief | Magic Spray for Pain Relief | Magic Spray for Pain Relief | Magic Spray for Pain Relief | Magic Spray for Pain Relief; product code is 60 - - - -- Human and Animal Drugs | 61 - - - -- Human and Animal Drugs | 62 - - - -- Human and Animal Drugs | 63 - - - -- Human and Animal Drugs | 64 - - - -- Human and Animal Drugs | 65 - - - -- Human and Animal Drugs | 66 - - - -- Human and Animal Drugs; date published is 03/05/2020; address is Building 1 Room 202 , No. 33 Yong South Rd; Nanshui Zhen Jinwan , Zhuhai, Guangdong CHINA, verified against its source on 2026-09-16.
- Firm
- Zhuhai Aofute Medical Technology Co., Ltd. verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- CHINA verified
- Address
- Building 1 Room 202 , No. 33 Yong South Rd; Nanshui Zhen Jinwan , Zhuhai, Guangdong CHINA verified
- Date published
- 03/05/2020 verified
- Product code
- 60 - - - -- Human and Animal Drugs | 61 - - - -- Human and Animal Drugs | 62 - - - -- Human and Animal Drugs | 63 - - - -- Human and Animal Drugs | 64 - - - -- Human and Animal Drugs | 65 - - - -- Human and Animal Drugs | 66 - - - -- Human and Animal Drugs each item verified
- Product
- Magic Spray for Pain Relief | Magic Spray for Pain Relief | Magic Spray for Pain Relief | Magic Spray for Pain Relief | Magic Spray for Pain Relief | Magic Spray for Pain Relief | Magic Spray for Pain Relief each item verified
- FDA notes
- Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. | Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. | Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. | Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. | Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. | Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. | Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. each item verified
What the source says
Zhuhai Aofute Medical Technology Co., Ltd. Date Published : 03/05/2020 Building 1 Room 202 , No. 33 Yong South Rd; Nanshui Zhen Jinwan , Zhuhai, Guangdong CHINA 60 - - - -- Human and Animal Drugs Date Published: 03/05/2020 Desc: Magic Spray for Pain Relief Notes: Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. 61 - - - -- Human and Animal Drugs Date Published: 03/05/2020 Desc: Magic Spray for Pain Relief Notes: Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. 62 - - - -- Human and Animal Drugs Date Published: 03/05/2020 Desc: Magic Spray for Pain Relief Notes: Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. 63 - - - -- Human and Animal Drugs Date Published: 03/05/2020 Desc: Magic Spray for Pain Relief Notes: Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. 64 - - - -- Human and Animal Drugs Date Published: 03/05/2020 Desc: Magic Spray for Pain Relief Notes: Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. 65 - - - -- Human and Animal Drugs Date Published: 03/05/2020 Desc: Magic Spray for Pain Relief Notes: Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling. 66 - - - -- Human and Animal Drugs Date Published: 03/05/2020 Desc: Magic Spray for Pain Relief Notes: Product appears to be adulterated within the meaning of section 501 (a)(2)(B) of the Act in that the methods used in or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with CGMP requirements. Product is a "drug" as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Product is intended for use as an external analgesic. Product is a new drug as formulated and labeled, within the meaning of section 201(p) of the FD&C Act, because it is not generally recognized among scientific experts as safe and effective for the drug uses described in its labeling.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.